Marshall Wace, LLP Sensus Healthcare, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 46,962 shares of SRTS stock, worth $246,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,962
Previous 132,286
64.5%
Holding current value
$246,550
Previous $906,000
75.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SRTS
# of Institutions
58Shares Held
4.76MCall Options Held
16.6KPut Options Held
23.3K-
Vanguard Group Inc Valley Forge, PA740KShares$3.89 Million0.0% of portfolio
-
Kingstone Capital Partners Texas, LLC Frisco, TX669KShares$3.51 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX542KShares$2.84 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA377KShares$1.98 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$1.36 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $86.9M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...